Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II study.

Bergmann, L

Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II study. [electronic resource] - Cancer Sep 1993 - 1733-42 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

0008-543X

10.1002/1097-0142(19930901)72:5<1733::aid-cncr2820720537>3.0.co;2-x doi


Aged
Aged, 80 and over
Carcinoma, Renal Cell--blood
Drug Administration Schedule
Drug Combinations
Female
Humans
Infusions, Intravenous
Interferon alpha-2
Interferon-alpha--administration & dosage
Interferon-gamma--blood
Interleukin-2--administration & dosage
Interleukin-6--blood
Kidney Neoplasms--blood
Leukocyte Count
Lymphocyte Subsets--pathology
Male
Middle Aged
Neoplasm Recurrence, Local--therapy
Receptors, Interleukin-2--analysis
Recombinant Proteins
Remission Induction
T-Lymphocyte Subsets--pathology
Tumor Necrosis Factor-alpha--analysis